Neogen (NEOG) Competitors $5.59 -0.14 (-2.44%) Closing price 04:00 PM EasternExtended Trading$5.60 +0.00 (+0.09%) As of 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NEOG vs. ICUI, XRAY, HAE, QDEL, STAA, CERS, OSUR, UTMD, ANIK, and WSTShould you be buying Neogen stock or one of its competitors? The main competitors of Neogen include ICU Medical (ICUI), DENTSPLY SIRONA (XRAY), Haemonetics (HAE), QuidelOrtho (QDEL), STAAR Surgical (STAA), Cerus (CERS), OraSure Technologies (OSUR), Utah Medical Products (UTMD), Anika Therapeutics (ANIK), and West Pharmaceutical Services (WST). These companies are all part of the "health care supplies" industry. Neogen vs. Its Competitors ICU Medical DENTSPLY SIRONA Haemonetics QuidelOrtho STAAR Surgical Cerus OraSure Technologies Utah Medical Products Anika Therapeutics West Pharmaceutical Services ICU Medical (NASDAQ:ICUI) and Neogen (NASDAQ:NEOG) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, earnings, dividends, media sentiment, analyst recommendations, institutional ownership, risk and valuation. Do insiders and institutionals have more ownership in ICUI or NEOG? 96.1% of ICU Medical shares are held by institutional investors. Comparatively, 96.7% of Neogen shares are held by institutional investors. 1.5% of ICU Medical shares are held by insiders. Comparatively, 1.1% of Neogen shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Do analysts recommend ICUI or NEOG? ICU Medical currently has a consensus target price of $181.00, suggesting a potential upside of 35.42%. Neogen has a consensus target price of $7.50, suggesting a potential upside of 34.77%. Given ICU Medical's stronger consensus rating and higher possible upside, research analysts clearly believe ICU Medical is more favorable than Neogen.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ICU Medical 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.00Neogen 0 Sell rating(s) 3 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.25 Which has more volatility and risk, ICUI or NEOG? ICU Medical has a beta of 0.86, indicating that its stock price is 14% less volatile than the S&P 500. Comparatively, Neogen has a beta of 1.84, indicating that its stock price is 84% more volatile than the S&P 500. Which has better earnings and valuation, ICUI or NEOG? ICU Medical has higher revenue and earnings than Neogen. ICU Medical is trading at a lower price-to-earnings ratio than Neogen, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioICU Medical$2.38B1.39-$117.69M-$1.52-87.93Neogen$894.66M1.35-$1.09B-$5.03-1.11 Is ICUI or NEOG more profitable? ICU Medical has a net margin of -1.56% compared to Neogen's net margin of -122.06%. ICU Medical's return on equity of 7.24% beat Neogen's return on equity.Company Net Margins Return on Equity Return on Assets ICU Medical-1.56% 7.24% 3.50% Neogen -122.06%2.39%1.57% Does the media favor ICUI or NEOG? In the previous week, Neogen had 34 more articles in the media than ICU Medical. MarketBeat recorded 46 mentions for Neogen and 12 mentions for ICU Medical. ICU Medical's average media sentiment score of 1.25 beat Neogen's score of 0.25 indicating that ICU Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment ICU Medical 7 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Neogen 11 Very Positive mention(s) 4 Positive mention(s) 23 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryICU Medical beats Neogen on 13 of the 17 factors compared between the two stocks. Get Neogen News Delivered to You Automatically Sign up to receive the latest news and ratings for NEOG and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NEOG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NEOG vs. The Competition Export to ExcelMetricNeogenMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.20B$10.62B$5.76B$10.02BDividend YieldN/A1.84%5.28%4.52%P/E Ratio-1.1021.5375.4026.14Price / Sales1.3530.83515.17171.54Price / Cash0.9824.6337.2059.76Price / Book0.583.5211.536.20Net Income-$1.09B$212.34M$3.28B$270.56M7 Day Performance-2.71%-0.39%0.84%2.94%1 Month Performance9.55%16.02%10.99%8.93%1 Year Performance-63.98%-8.73%61.77%27.61% Neogen Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NEOGNeogen3.4585 of 5 stars$5.59-2.4%$7.50+34.2%-62.7%$1.21B$894.66M-1.112,110ICUIICU Medical4.734 of 5 stars$130.58-0.5%$179.00+37.1%-21.1%$3.24B$2.38B-85.9115,000News CoveragePositive NewsAnalyst ForecastXRAYDENTSPLY SIRONA4.9275 of 5 stars$14.21-2.8%$18.64+31.1%-45.1%$2.92B$3.79B-3.0014,000HAEHaemonetics4.8149 of 5 stars$54.02-0.7%$85.18+57.7%-25.5%$2.62B$1.35B16.523,023Short Interest ↑Analyst RevisionQDELQuidelOrtho4.3631 of 5 stars$28.47-0.7%$39.20+37.7%-36.1%$1.95B$2.78B-4.356,600Positive NewsSTAASTAAR Surgical3.0096 of 5 stars$27.69-0.9%$20.67-25.4%-7.9%$1.38B$313.90M-14.351,211CERSCerus1.9726 of 5 stars$1.30-2.3%$3.50+169.2%-36.1%$254.96M$180.27M-13.00290News CoverageShort Interest ↑OSUROraSure Technologies2.5891 of 5 stars$3.25+0.6%$3.00-7.7%-20.4%$236.23M$185.83M-4.85840News CoverageUTMDUtah Medical Products2.5056 of 5 stars$63.35-0.1%N/A-5.0%$203.24M$40.90M16.95180Positive NewsANIKAnika Therapeutics4.2404 of 5 stars$8.94flat$18.00+101.3%-64.0%$128.90M$114.55M-2.15300WSTWest Pharmaceutical Services4.9761 of 5 stars$253.30+1.0%$320.71+26.6%-16.5%$18.03B$2.89B37.9210,600Positive News Related Companies and Tools Related Companies ICUI Competitors XRAY Competitors HAE Competitors QDEL Competitors STAA Competitors CERS Competitors OSUR Competitors UTMD Competitors ANIK Competitors WST Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NEOG) was last updated on 9/10/2025 by MarketBeat.com Staff From Our PartnersThis stock just surpassed PalantirThe media hasn't caught up to the story yet, but when they do, this stock could leave Nvidia in the dust. I...InvestorPlace | SponsoredOne tiny company just cracked Google’s $19B problemTucked away outside San Antonio sits a facility most Americans don’t know exists. It’s not mining gold or o...True Market Insiders | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAlert: Prepare for Trump's Dollar OverhaulPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredTrump’s reported death a hoaxHow Trump’s latest policies could trigger a full-scale debt collapse… And the specific investments that cou...Porter & Company | SponsoredWorld War 3? Everything Just Changed — and One Tiny Company Is at the Center of It.Trump immediately activated a $5.3 TRILLION AI missile shield — code-named Golden Dome — to stop drone swarms ...Angel Publishing | SponsoredLitecoin’s Creator Backs the World’s First TreasuryBitcoin's corporate adoption story has been written. Litecoin's is just beginning.The Tomorrow Investor | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neogen Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Neogen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NEOG Stock Alerts